AQP1 and glioblastoma: Outcomes of this work support the idea that channel inhibitors might be repurposed to control motility in GBM cells; combinations of ion channel pharmacological agents with an AQP1 water pore blocker created strong anti-invasive treatments for GBM cell lines.